Drug Development
Topic
Check out the latest Drug Development news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
LATEST DRUG DEVELOPMENT NEWS
Health Check: Telix edges closer to a radiotherapy for difficult brain cancers
Health Check: Trump says a pharma tax is in the offing – with no negotiation
Health Check: Yippee! Biotechs join broader rally after Trump tariff turnaround
Health Check: Drug sector panic sets in at the prospect of a Trump tariff ‘pharma-geddon’
Health Kick Podcast: Deep dive into AdAlta’s East to West strategy
Health Check: Relax! Tariffs shape as the next Y2K as biotechs report ‘nothing to see here’
Long Shortz with Orthocell: Remplir gets FDA green light
Health Check: We’re ‘duty free’, declare several ASX life science companies
Race activates its first Phase I trial site for cardioprotective anticancer drug candidate
Health Check: Liberation Day spares the global drug sector – for now
Biocurious: While other biotechs scratch around for cash, Clinuvel is accused of having too much
StockTake: Neurizon’s lead asset shows positive results in latest study
Health Check: It’s a CEO changing of the guard at Mach 7 and Universal Biosensors
